Lidón Carretero-Vilarroig

Mrs. Lidón Carretero-Vilarroig


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Miguel ArmengotMiguel Armengot
Miguel Armengot
CDCatalina Bancalari Díaz
Catalina Bancalari Díaz
LCLidón Carretero-Vilarroig
Lidón Carretero-Vilarroig
RBRosana Blanco-Máñez
Rosana Blanco-Máñez
NMNoelia Muñoz-Fernández
Noelia Muñoz-Fernández
TSTeresa Jaijo Sanchis
Teresa Jaijo Sanchis
Background and Objective: Primary ciliary dyskinesia (PCD) is a rare genetic disorder that affects the mucociliary system, leading to progressive lung damage. This deterioration can result in bronchiectasis, atelectasis, and respiratory failure, necessitating lung transplantation in severe cases. This study aims to assess ciliary motility and ultrastructure in the bronchial epithelium of transplanted lungs in patients with PCD to determine whether mucociliary function is preserved post-transplantation. The findings seek to enhance scientific understanding and provide prognostic insights for these patients. Materials and Methods: A prospective observational study was conducted on two patients with PCD and advanced lung disease who underwent bilateral lung transplantation. Nasal and bronchial cilia samples were analyzed using high-speed videomicroscopy and transmission electron microscopy. Follow-up assessments included ciliary function analysis, lung rejection monitoring, and quality-of-life evaluations, with follow-up extending up to 30 months post-transplant. Results: Post-transplant evaluations demonstrated normal ciliary motility and ultrastructure in the transplanted lungs throughout the study period (up to 30 months), indicating the long-term preservation of mucociliary function. Conclusions: Transplanted lungs in patients with PCD maintain normal bronchial ciliary motility and structure in the long term, suggesting a favorable prognosis for both the graft and the recipient. These findings support the feasibility and long-term effectiveness of lung transplantation in patients with PCD.

4 June 2026 in Respiratory Medicine
Verified
Journal Article
Open access
LCLidón Carretero-Vilarroig
Lidón Carretero-Vilarroig
TSTeresa Jaijo Sanchis
Teresa Jaijo Sanchis
JLJane S Lucas
Jane S Lucas
LBLaura Behan
Laura Behan
FDFrancisco Dasí
Francisco Dasí
ARAna Reula
Ana Reula
The Quality-of-Life Primary Ciliary Dyskinesia (QOL-PCD) instrument is the only health-related QOL instrument specific to measuring patient-reported outcomes in PCD patients. The adaptation and validation of the Spanish version of this questionnaire is a crucial step in formulating effective healthcare strategies that will improve the quality of life of these patients within the Spanish context. In this regard, the objective of the study was to cross-culturally adapt and pilot-validate a Spanish version for patients with PCD. A total of 21 Spanish patients with PCD participated in this study. The QOL-PCD was translated and cross-culturally adapted following BESTCILIA Work Package 4 and ISPOR recommendations, respectively. Pilot psychometric validation was explored through internal consistency (Cronbach's α) and construct validity studies. Stability and convergent validity were studied in eight patients. QoL analyses were performed using Pearson correlations and a Welch t-test. The Spanish QOL-PCD questionnaire included 40 items evaluating the ten original scales. All participants demonstrated a clear understanding of the questionnaire. All scales shown moderate to good internal consistency. Test-retest reliability proved particularly strong for Physical Functioning, Vitality, Emotional Functioning, Role and Social Functioning. SF-36 and SNOT-22 comparisons demonstrated moderate to high correlations. As hypothesized, a positive correlation was found between lower respiratory symptoms and history of lung transplantation. The Spanish QOL-PCD questionnaire has robust psychometric properties and is therefore a validated tool for assessing quality of life (QoL) in Spanish adults with primary ciliary dyskinesia (PCD). This work will improve patient care and inform future PCD research.